Immunic stockholder votes authorize reverse split at 1-for-10, effective April 27, 2026

IMMUNIC, INC.

Stockholders approved reverse stock split with 57.4M votes for, 12.6M against, 0.6M abstentions.
Board set split ratio at 1-for-10, effective 12:01 a.m. ET on April 27, 2026.
New common stock to trade under same symbol 'IMUX' on Nasdaq starting April 27, 2026.
New CUSIP identifier for post-split shares: 4525EP200.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.